$15.27
-0.56-3.54%
At close: -
$15.27
0.000.00%
After Hours: Dec 27, 4:30 PM EDT
Arcus Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcus Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-1.00 | $-1.06 | 5.66 % |
Jun 2024 | 2024-08-08 | $-1.02 | $-1.10 | 7.27 % |
Mar 2024 | 2024-05-08 | $-0.05 | $-0.93 | 94.6 % |
Dec 2023 | 2024-02-21 | $-1.08 | $-1.02 | -5.88 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $48.00M | $37.56M | 27.8 % |
Jun 2024 | 2024-08-08 | $39.00M | $25.61M | 52.3 % |
Mar 2024 | 2024-05-08 | $145.00M | $35.56M | 307.8 % |
Dec 2023 | 2024-02-21 | $31.00M | $28.37M | 9.27 % |
Arcus Biosciences (RCUS) is scheduled to report earnings on February 19, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-1.00, which beat the estimate of $-1.06.
The Actual Revenue was $48M, which beat the estimate of $37.6M.
Browse earnings estimates, EPS, and revenue on all stocks.